Evidence map›Paper›PMID 28433422›Full record

ArticleAlcohol (Fayetteville, N.Y.)2017

Postnatal choline supplementation selectively attenuates hippocampal microRNA alterations associated with developmental alcohol exposure.

Sridevi Balaraman, Nirelia M Idrus, Rajesh C Miranda, Jennifer D Thomas

Open access · greenAbstract read
In one paragraph

Article in Alcohol (Fayetteville, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sridevi BalaramanDepartment of Neuroscience and Experimental Therapeutics, Women's Health in Neuroscience Program, College of Medicine, Texas A&M Health Science Center, College Station, TX 77843, USA.
Nirelia M IdrusCenter for Behavioral Teratology, Department of Psychology, San Diego State University, San Diego, CA 92120, USA.
Rajesh C MirandaDepartment of Neuroscience and Experimental Therapeutics, Women's Health in Neuroscience Program, College of Medicine, Texas A&M Health Science Center, College Station, TX 77843, USA.
Jennifer D ThomasCenter for Behavioral Teratology, Department of Psychology, San Diego State University, San Diego, CA 92120, USA. Electronic address: Thomas3@mail.sdsu.edu.
San Diego State University · USTexas A&M Health Science Center · US

Funding

UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian Michael Carroll · 1999 to 2026
$31.6M
Fetal Alcohol Effects and Choline InterventionR01AA012446 · NIAAA · SAN DIEGO STATE UNIVERSITY · PI THOMAS, JENNIFER D · 2001 to 2015
$3.8M
Fetal Alcohol Effects and Choline InterventionR37AA012446 · NIAAA · SAN DIEGO STATE UNIVERSITY · PI JENNIFER D THOMAS · 2018 to 2026
$3.1M
Fetal Alcohol Exposure and NeurodevelopmentR01AA013440 · NIAAA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MIRANDA, RAJESH C · 2002 to 2012
$2.7M
Prenatal microRNA neuro-therapeutics for fetal alcohol exposureR01AA024659 · NIAAA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MIRANDA, RAJESH C · 2016 to 2020
$1.8M
Fetal Alcohol Exposure and NeurodevelopmentR56AA013440 · NIAAA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MIRANDA, RAJESH C · 2007 to 2007
$292k
NIAAA NIH HHS R01 AA012446NIAAA NIH HHS R01 AA013440NIAAA NIH HHS R01 AA024659NIAAA NIH HHS R37 AA012446NIAAA NIH HHS R56 AA013440NIDDK NIH HHS P30 DK056350
6 · The paper itself

Abstract

Prenatal alcohol exposure can result in a range of physical, neuropathological, and behavioral alterations, collectively termed fetal alcohol spectrum disorders (FASD). We have shown that supplementation with the nutrient choline reduces the severity of developmental alcohol-associated deficits in hippocampal-dependent behaviors and normalizes some aspects of hippocampal cholinergic development and DNA methylation patterns. Alcohol's developmental effects may also be mediated, in part, by altering microRNAs (miRNAs) that serve as negative regulators of gene translation. To determine whether choline supplementation alters ethanol's long-lasting effects on miRNAs, Sprague-Dawley rats were exposed to 5.25 g/kg/day ethanol from postnatal days (PD) 4-9 via intubation; controls received sham intubations. Subjects were treated with choline chloride (100 mg/kg/day) or saline vehicle subcutaneously (s.c.) from PD 4-21. On PD 22, subjects were sacrificed, and RNA was isolated from the hippocampus. MiRNA expression was assessed with TaqMan Human MicroRNA Panel Low-Density Arrays. Ethanol significantly increased miRNA expression variance, an effect that was attenuated with choline supplementation. Cluster analysis of stably expressed miRNAs that exceeded an ANOVA p < 0.05 criterion indicated that for both male and female offspring, control and ethanol-exposed groups were most dissimilar from each other, with choline-supplemented groups in between. MiRNAs that expressed an average 2-fold change due to ethanol exposure were further analyzed to identify which ethanol-sensitive miRNAs were protected by choline supplementation. We found that at a false discovery rate (FDR)-adjusted criterion of p < 0.05, miR-200c was induced by ethanol exposure and that choline prevented this effect. Collectively, our data show that choline supplementation can normalize disturbances in miRNA expression following developmental alcohol exposure and can protect specific miRNAs from induction by ethanol. These findings have important implications for the mechanisms by which choline may serve as a potential treatment for FASD.

Indexed as

EthanolAnimalsAnimals, NewbornBlood Alcohol ContentCholineDisease Models, AnimalFemaleFetal Alcohol Spectrum DisordersGene Expression Regulation, DevelopmentalHippocampusMaleMicroRNAsNeuroprotective AgentsRats, Sprague-DawleyTime FactorsWeight GainBlood Alcohol ContentCholineEthanolMicroRNAsMIRN200 microRNA, ratNeuroprotective AgentsCholineFetal alcoholGeneticInterventionmiRNA

Identifiers

PMID28433422
PMCPMC5559286
OpenAlexW2568777459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.